Actively Recruiting

Age: 18Years +
All Genders
NCT06791941

Study of the Contribution of Mutant p53/YAP Proteins to Therapy Resistance in Recurrent Head and Neck Cancer

Led by Regina Elena Cancer Institute · Updated on 2025-01-24

18

Participants Needed

1

Research Sites

260 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Multicenter, non-interventional, retrospective/prospective study of a biological nature, on patients affected by head and neck tumors, for which the collection and use of tissue samples is planned for the study of the mutational profile, the transcriptional profile and the proteomic profile.

CONDITIONS

Official Title

Study of the Contribution of Mutant p53/YAP Proteins to Therapy Resistance in Recurrent Head and Neck Cancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age over 18
  • Patients with squamous cell tumors of the oral cavity, pharynx or larynx
  • Surgical patients with primary HNSCC tumors, who have not had previous tumors in other sites or adjuvant treatments prior to surgery
  • Availability of adequate material (tissue) for the planned analyses
  • Availability of follow-up data for at least one year (retrospective part)
  • Written informed consent (prospective part and/or, for the retrospective part, traceable patients and/or patients in follow-up and/or if necessary for the legal nature/institutional purposes of the participating centers)
Not Eligible

You will not qualify if you...

  • Presence of distant metastases at the time of diagnosis
  • Previous head and neck cancer
  • Second cancer undergoing treatment or follow-up for less than 5 years

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

IRCCS National Cancer institute

Roma, Rome, Italy, 00144

Actively Recruiting

Loading map...

Research Team

G

Giovanni Blandino, Doctor

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Study of the Contribution of Mutant p53/YAP Proteins to Therapy Resistance in Recurrent Head and Neck Cancer | DecenTrialz